Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shiva Malek

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Nature

Multidisciplinary

2013

English

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

English

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

English

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches

English

Identification of Preferred Chemotherapeutics for Combining With a CHK1 Inhibitor

Molecular Cancer Therapeutics

Cancer Research

Oncology

2013

English

IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells

Journal of Biological Chemistry

English

Mechanism of κB DNA Binding by Rel/NF-κB Dimers

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shiva Malek

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches

Identification of Preferred Chemotherapeutics for Combining With a CHK1 Inhibitor

IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells

Mechanism of κB DNA Binding by Rel/NF-κB Dimers